Sinofresh Petition Does Not Support CPC Oral Antiseptic Use – Schering
This article was originally published in The Tan Sheet
Executive Summary
A citizen petition filed by Sinofresh seeking to classify .05% cetylpyridium chloride (CPC) as a Category I oral antiseptic drug represents an inappropriate attempt to include a nasal spray in a monograph for oral health care products, Schering-Plough Healthcare states in recent comments to FDA
You may also be interested in...
Cetylpyridinium Nasal Spray Status As Category I Oral Antiseptic Requested
Inclusion of a nasal spray containing .05% cetylpyridinium chloride in FDA's tentative final monograph for Oral Antiseptic Drug Products is requested by SinoFresh Research Labs in a March 24 citizen petition
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands